⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001870491

Sands Capital Ventures Discovery Fund III, L.P.

Reports to the SEC for 1 company · ARLINGTON, VA

Transactions

5

Companies

1

Filings

1

CIK

0001870491

Forms 4 and 5

Insider transactions

5 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-07-06	ABOSAcumen Pharmaceuticals, Inc.C Conversion	10% Owner	CConversion	+1.12M sh	—	—	1,124,729
2021-07-06	ABOSAcumen Pharmaceuticals, Inc.C Conversion	10% Owner	CConversion	+1.84M sh	—	—	2,967,075
2021-07-06	ABOSAcumen Pharmaceuticals, Inc.P Purchase	10% Owner	PPurchase	+450K sh	$14.88	+$6.7M	3,417,075
2021-07-06	ABOSAcumen Pharmaceuticals, Inc. · Series A-1 Preferred StockC Conversion	10% Owner	CConversion	−1.12M sh	—	—	0
2021-07-06	ABOSAcumen Pharmaceuticals, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−1.84M sh	—	—	0

Recent filings

1

Accepted (ET)
Jul 84
Sands Capital Ventures Discovery Fund III, L.P.0000899243-21-027891
SEC(opens sec.gov)

Companies

1

Acumen Pharmaceuticals, Inc.10% OwnerABOS

Address

1000 WILSON BLVD., SUITE 3000

ARLINGTON, VA, 22209